92
Participants
Start Date
February 7, 2024
Primary Completion Date
February 7, 2031
Study Completion Date
February 7, 2031
Optilume® BPH Catheter System
The Optilume BPH Catheter System is a combination drug/device minimally invasive surgical therapy (MIST) comprised of an uncoated pre-dilation balloon catheter and a separate drug coated balloon (DCB) catheter. The distal end of each catheter has a semi-compliant, inflatable, double lobe balloon that is used to dilate the prostate. The double-lobe DCB catheter is coated with a proprietary coating containing the active pharmaceutical agent paclitaxel. The drug coating covers the working length of the balloon body.
RECRUITING
Florida Urology Partners, LLP, Tampa
RECRUITING
Ochsner LSU Health Shreveport - Regional Urology, Shreveport
RECRUITING
Arkansas Urology, Little Rock
RECRUITING
Midtown Urology Associates, Austin
RECRUITING
Sheldon Freedman MD, Ltd, Las Vegas
Urotronic Inc.
INDUSTRY